- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 38/49 - UrokinaseActivateur du plasminogène
Détention brevets de la classe A61K 38/49
Brevets de cette classe: 271
Historique des publications depuis 10 ans
|
8
|
20
|
26
|
29
|
29
|
13
|
12
|
16
|
23
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Talengen International Limited | 86 |
15 |
| Thornhill Therapeutics, Inc. | 33 |
10 |
| Remedy Pharmaceuticals, Inc. | 57 |
7 |
| The Research Foundation for The State University of New York | 1781 |
7 |
| Children's Medical Center Corporation | 1978 |
6 |
| Board of Regents, The University of Texas System | 6187 |
5 |
| National Jewish Health | 170 |
5 |
| Shimojani, LLC | 7 |
5 |
| The United States Government AS represented by The Department of Veterans Affairs | 1358 |
5 |
| Annexin Pharmaceuticals AB | 22 |
4 |
| Case Western Reserve University | 1911 |
4 |
| NoNO Inc. | 68 |
4 |
| Thrombolytic Science, LLC | 6 |
4 |
| Genentech, Inc. | 4157 |
3 |
| The Board of Trustees of the Leland Stanford Junior University | 6724 |
3 |
| The Regents of the University of Michigan | 5063 |
3 |
| Vertex Pharmaceuticals Incorporated | 1578 |
3 |
| Hadasit Medical Research Services & Development Limited | 131 |
3 |
| Icahn School of Medicine at Mount Sinai | 1058 |
3 |
| Indiana University Research and Technology Corporation | 780 |
3 |
| Autres propriétaires | 169 |